Vav1 haploinsufficiency in a common variable immunodeficiency patient with defective t-cell function

International Journal of Immunopathology and Pharmacology

Volumn 25, Issue 3, 2012, Pages 811-817

  Capitani, N ^a   Ariani, F ^a   Amedep, A ^b   Pezzicoli, A ^a   Matucci, A ^c   Vultaggio, A ^c   Troilo, A ^b   Renieri, A ^a   Baldari, C T ^a   D'Elios, M M ^b  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

CVID; Gene dosage; Gene expression; Tcr signaling; Vav

Indexed keywords

ANTIBIOTIC AGENT; CD19 ANTIGEN; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MESSENGER RNA; PROTEIN; UNCLASSIFIED DRUG; VAV1 PROTEIN;

AGED; ARTICLE; CASE REPORT; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL FUNCTION; COMMON VARIABLE IMMUNODEFICIENCY; CONTROLLED STUDY; CPG ISLAND; CYTOKINE PRODUCTION; DNA FLANKING REGION; DNA METHYLATION; DNA MODIFICATION; EPIGENETICS; EXON; FEMALE; GENE DELETION; GENE EXPRESSION; GENE FREQUENCY; GENE IDENTIFICATION; GENE MAPPING; GENE SILENCING; HAPLOINSUFFICIENCY; HETEROZYGOSITY; HUMAN; PEDIGREE; POINT MUTATION; POLYADENYLATION; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 84868014580     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463201202500332     Document Type: Article

References (25)

1. Rosen FS, Cooper MD, Wedgwood RJ. The primary immunodeficiencies. N Engl J Med 1995; 333: 431-40.
2. Sneller MC. Common variable immunodeficiency. Am J Med Sci 2001; 321:42-48. (Pubitemid 32053230)
3. Spickett GP Current perspectives on common variable immunodeficiency (CVID). Clin Exp Allergy 2001; 31: 536-42.
4. Buckley RH. Primary immunodeficiency diseases due to defects in lymphocytes. N Engl J Med 2000; 343: 1313-24.
5. Grimbacher B, Hutloff A, Schlesier M, et al. Homozygous loss of ICOS is associated with adultonset common variable immunodeficiency. Nat Immunol 2003; 4:261-68. (Pubitemid 36322136)
6. Fischer MB, Hauber I, Eggenbauer H, et al. A defect in the early phase of T-cell receptor-mediated T-cell activation in patients with common variable immunodeficiency. Blood 1994; 84:4234-41. (Pubitemid 24371927)
7. Fischer MB, Wolf HM, Hauber I, et al. Activation via the antigen receptor is impaired in T cells, but not in B cells from patients with common variable immunodeficiency. Eur J Immunol 1996; 26:231-37. (Pubitemid 26028439)
8. Sawabe T, Horiuchi T, Nakamura M, Tsukamoto H, Nakahara K, Harashima SI, Tsuchiya T, Nakano S. Defect of lck in a patient with common variable immunodeficiency. Int J Mol Med 2001; 7: 609-14.
9. Majolini MB, D'Elios MM, Boncristiano M, et al. Uncoupling of T-cell antigen receptor and downstream protein tyrosine kinases in common variable immunodeficiency. Clin Immunol Immunopathol 1997; 84:98-102. (Pubitemid 27293549)
10. Boncristiano M, Majolini MB, D'Elios MM, et al. Defective recruitment and activation of ZAP-70 in common variable immunodeficiency patients with T cell defects. Eur J Immunol 2000; 30: 2632-38.
11. Paccani SR, Boncristiano M, D'Elios MM, et al. Defective Vav expression and impaired F-actin reorganization in a subset of patients with common variable immunodeficiency characterized by T-cell defects. Blood 2005; 106:626-34. (Pubitemid 40981260)
12. Drevot P, Langlet C, Guo XJ, Bernard AM, Colard O, Chauvin JP, Lasserre R, He HT. TCR signal initiation machinery is pre-assembled and activated in a subset of membrane rafts. Embo J 2002; 21:1899-1908. (Pubitemid 34437187)
13. Bustelo XR. Regulatory and signaling properties of the Vav family. Mol Cell Biol 2000; 20:1461-77. (Pubitemid 30100166)
14. Capitani N, Amedei A, Paccani SR, et al. Impaired TH2 response in patients with Vav 1-deficient common variable immunodeficiency with T-cell defects. J Allergy Clin Immunol 2010; 126: 671 -75.
15. Tanaka Y, So T, Lebedeva S, Croft M, Altman A. Impaired IL-4 and c-Maf expression and enhanced Th1-cell development in Vav 1-deficient mice. Blood 2005; 106:1286-95. (Pubitemid 41129592)
16. Pezzicoli A, Ulivieri C, Capitani N, et al. Expression in T-cells of the proapoptotic protein p66SHC is controlled by promoter demethylation. Biochem Biophys Res Commun 2006; 349:322-28. (Pubitemid 44331796)
17. Kuimelis RG, Livak KJ, Mullah B, Andrus A. Structural analogues of TaqMan probes for real-time quantitative PCR. Nucleic Acids Symp Ser 1997; 37: 255-256.
18. Shames DS, Minna JD, Gazdar AF. DNA methylation in health, disease, and cancer. Curr Mol Med 2007; 7:85-102. (Pubitemid 46322281)
19. Denkinger DJ, Borges CR, Butler CL, Cushman AM, Kawahara RS. Genomic organization and regulation of the vav proto-oncogene. Biochim Biophys Acta 2000; 1491:253-62. (Pubitemid 30173350)
20. Fujikawa K, Miletic AV, Alt FW, et al. Vavl/2/3-null mice define an essential role for Vav family proteins in lymphocyte development and activation but a differential requirement in MAPK signaling in T and B cells. J Exp Med 2003; 198:1595-608. (Pubitemid 37467173)
21. Hornstein I, Alcover A, Katzav S. Vav proteins, masters of the world of cytoskeleton organization. Cell Signal 2004; 16: 1-11.
22. Wulfing C, Bauch A, Crabtree GR, Davis MM. The vav exchange factor is an essential regulator in actin-dependent receptor translocation to the lymphocyte-antigen-presenting cell interface. Proc Natl Acad Sci U S A 2000; 97: 10150-55.
23. Chiang J, Hodes RJ. Cbl enforces Vavl dependence and a restricted pathway of T cell development. PLoS One. 2011; 6: el8542.
24. Aspalter RM, Eibl MM, Wolf HM. Defective T-cell activation caused by impairment of the TNF receptor 2 costimulatory pathway in common variable immunodeficiency. J Allergy Clin Immunol 2007;120:1193-200. (Pubitemid 350029891)
25. Bachmann MF, Nitschke L, Krawczyk C, et al. The guanine-nucleotide exchange factor Vav is a crucial regulator of B cell receptor activation and B cell responses to nonrepetitive antigens. J Immunol 1999; 163:137-42. (Pubitemid 29295834)